The Lupus Research Institute (LRI) and its National Coalition of state and local lupus agencies are delighted with the U. S. Food and Drug Administration (FDA) Advisory Committee’s vote to advocate approval of Benlysta® for active systemic lupus erythematosus[SLE], offering sufferers new found desire for the first authorised treatment choice in more than Half a [...]
http://tinyurl.com/2uuskgv
No comments:
Post a Comment